SCHEMBL23748677

SCHEMBL23748677

O=C(CCl)Nc1ccc(Oc2ccc3ccccc3c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNF4 P78317 1/20 0.75
ALDH1A1 P00352 6/20 0.65
HTT P42858 5/20 0.65
POLB P06746 3/20 0.65
MITF O75030 2/20 0.65
MAPK1 P28482 1/20 0.65
MEN1 O00255 6/20 0.59
KMT2A Q03164 6/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPT P10636 4/20 0.57
LMNA P02545 4/20 0.57
CYP1A2 P05177 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
CYP2C19 P33261 3/20 0.57
CYP3A4 P08684 2/20 0.57
GLA P06280 1/20 0.57
NPSR1 Q6W5P4 1/20 0.56
PARG Q86W56 1/20 0.55
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31536277 1.00 RNF4 (0.75) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL3382618 0.86 RNF4 (1.00) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL11806908 0.86 RNF4 (0.86) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL8901243 0.84 MAPT (0.72) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL29728198 0.84 MAPT (0.72) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL23373325 0.81 KDM4E (0.60) RNF4ALDH1A1HTTPOLBMEN1
SCHEMBL31703396 0.81 RNF4 (0.73) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL21392901 0.80 RNF4 (0.71) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL21392968 0.80 RNF4 (0.76) RNF4ALDH1A1HTTPOLBMITF
SCHEMBL24075754 0.79 RNF4 (0.69) RNF4ALDH1A1HTTPOLBMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12161648-B2 Covalent targeting of E3 ligases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-10 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
EP-3863642-A1 COVALENT TARGETING OF E3 LIGASES The Regents of the University of California (US) 2021-08-18 EP disclosed
CN-113164495-A Covalent targeting of E3 ligase 加利福尼亚大学董事会 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12161648-B2 Covalent targeting of E3 ligases RNF114, RNF4, RNF168 RNF4 2/4885ALDH1A1 2969/4885HTT 546/4885
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES RNF114, RNF4, RNF168 RNF4 2/4885ALDH1A1 2969/4885HTT 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.